Skip to main content

Research Repository

Advanced Search

The incidence and determinants of metabolic syndrome amongst a group of migrants to Qatar: a prospective longitudinal observational cohort study 24-months post-migration. (2021)
Journal Article
AL-ADAWI, R.M., PRABHU, K.S., STEWART, D., RYAN, C., ABDELAZIZ, H., ELEDRISI, M., IBRAHIM, M.I.M., UDDIN, S. and TONNA, A.P. 2022. The incidence and determinants of metabolic syndrome amongst a group of migrants to Qatar: a prospective longitudinal observational cohort study 24-months post-migration. Journal of clinical medicine [online], 11(1), article 34. Available from: https://doi.org/10.3390/jcm11010034

While there is some evidence that migration to Western countries increases metabolic syndrome (MetS) risk, there is a lack of data pertaining to migration to the Middle East. This study aimed to investigate the relationship between migration and MetS... Read More about The incidence and determinants of metabolic syndrome amongst a group of migrants to Qatar: a prospective longitudinal observational cohort study 24-months post-migration..

The incidence of metabolic syndrome amongst Qatar migrants 24 months post-migration: a prospective longitudinal observational cohort study. (2021)
Presentation / Conference
AL-ADAWI, R., PRABHU, K.S., RYAN, C., ABDELAZIZ, H., EL EDRISI, M. and IBRAHIM, M.I.M. 2021. The incidence of metabolic syndrome amongst Qatar migrants 24 month post-migration: a prospective longiudinal observational cohort study. Presented at 49th ESCP (European Society of Clinical Pharmacy) virtual symposium on clinical pharmacy (ESCP 2021): clinical pharmacy, working collaboratively in mental health care, 19-21 October 2021, [virtual conference].

Background and Objective: Evidence indicates that migration to Western countries is associated with increased metabolic syndrome (MetS) risk. There is, however, a scarcity of data about MetS incidence in migrants to Middle Eastern countries. This stu... Read More about The incidence of metabolic syndrome amongst Qatar migrants 24 months post-migration: a prospective longitudinal observational cohort study..

Incidence of co-trimoxazole-induced hyperkalemia in a tertiary care hospital. (2021)
Journal Article
AL ADAWI, R.M., ALBU-MAHMOOD, Z., ABDELGELIL, M., ABDELAZIZ, H., STEWART, D. and AWAISU, A. 2021. Incidence of co-trimoxazole-induced hyperkalemia in a tertiary care hospital. Risk management and healthcare policy [online], 14, pages 519-525. Available from: https://doi.org/10.2147/RMHP.S283471

Background: Co-trimoxazole is a broad-spectrum antibiotic associated with hyperkalemia. Objective: To determine the incidence of hyperkalemia and its risk factors in patients receiving co-trimoxazole. Materials and Methods: A retrospective observatio... Read More about Incidence of co-trimoxazole-induced hyperkalemia in a tertiary care hospital..

A systematic review of pharmacist input to metabolic syndrome screening, management and prevention. (2020)
Journal Article
AL ADAWI, R.M., STEWART, D., RYAN, C. and TONNA, A. 2020. A systematic review of pharmacist input to metabolic syndrome screening, management and prevention. International journal of clinical pharmacy [online], 42(4), pages 995-1015. Available from: https://doi.org/10.1007/s11096-020-01084-3

Metabolic syndrome is a cluster of factors that increase the risk of cardiovascular disease and include: diabetes and prediabetes, abdominal obesity, elevated triglycerides, low high-density lipoprotein cholesterol and high blood-pressure. However, t... Read More about A systematic review of pharmacist input to metabolic syndrome screening, management and prevention..

Ethanolic stem bark extract of terminalia ivorensis A. Chev. protects against potassium dichromate–induced nephrotoxicity in rats. (2020)
Journal Article
MOOMIN, A., MENSAH, K.B., FORKUO, A.D., ADU-GYAMFI, P.K.T. and ANSAH, C. 2020. Ethanolic stem bark extract of terminalia ivorensis A. Chev. protects against potassium dichromate-induced nephrotoxicity in rats. Scientific African [online], 8, article number e00410. Available from: https://doi.org/10.1016/j.sciaf.2020.e00410

Objective: The plant Terminalia ivorensis is used in traditional medicine as a diuretic and in the management of renal failure. We reported previously that the ethanol stem bark extract of the plant protects against gentamicin-induced renal and hepat... Read More about Ethanolic stem bark extract of terminalia ivorensis A. Chev. protects against potassium dichromate–induced nephrotoxicity in rats..

Evaluating the effectiveness of pneumococcal vaccines against hospitalization and intensive care unit admission in adults. (2019)
Journal Article
EL-BARDISSY, A.H.E., AL-ADAWI, R.M., SHIBLE, A.A., ALBU-MAHMOOD, Z., ELGAILY, D.E. and ABDELAZIZ, H. 2019. Evaluating the effectiveness of pneumococcal vaccines against hospitalization and intensive care unit admission in adults. Journal of pharmaceutical health services research [online], 10(4), pages 427-431. Available from: https://doi.org/10.1111/jphs.12321

Objective: To evaluate the efficacy of pneumococcal vaccines concerning hospital or intensive care unit (ICU) admissions due to pneumonia after vaccination. Setting: Inpatient and ICUs at Hamad General Hospital. Methods: The retrospective study inclu... Read More about Evaluating the effectiveness of pneumococcal vaccines against hospitalization and intensive care unit admission in adults..

Critical appraisal of the clinical practice guideline for the management of dyslipidaemia and prevention of cardiovascular disease: AACE 2017 guidelines. (2019)
Journal Article
ALKHAWAJA, R.M., MADI, L., ALHAMOUD, E., ABDALLAH, I., JAVED, M., FAYEZ, H. and AL-ADAWI, R.M. 2019. Critical appraisal of the clinical practice guideline for the management of dyslipidaemia and prevention of cardiovascular disease: AACE 2017 guidelines. Journal of pharmaceutical health services research [online], 10(3), pages 383-388. Available from: https://doi.org/10.1111/jphs.12302

Objective: This study aims to appraise 2017 AACE Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease by using Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool. Method: A total of seven investigator... Read More about Critical appraisal of the clinical practice guideline for the management of dyslipidaemia and prevention of cardiovascular disease: AACE 2017 guidelines..

Assessment of dapagliflozin effectiveness as add-on therapy for the treatment of type 2 diabetes mellitus in a Qatari population. (2019)
Journal Article
AL ADAWI, R.M., JASSIM, Z., ELGAILY, D., ABDELAZIZ, H., SREE, B. and MOHAMED IBRAHIM, M.I. 2019. Assessment of dapagliflozin effectiveness as add-on therapy for the treatment of type 2 diabetes mellitus in a Qatari population. Scientific reports [online], 9, article 6864. Available from: https://doi.org/10.1038/s41598-019-43052-6

The effectiveness of dapagliflozin in the management of type-2 diabetes mellitus (T2-DM) is an essential issue for establishing a basis for prescribing dapagliflozin. This study aimed to assess the effectiveness of dapagliflozin in combination with o... Read More about Assessment of dapagliflozin effectiveness as add-on therapy for the treatment of type 2 diabetes mellitus in a Qatari population..

Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus. (2018)
Journal Article
ELEDRISI, M., SULEIMAN, N.N., SALAMEH, O., HAMAD, M.K., RABADI, O., MOHAMED, A., AL ADAWI, R. and SALAM, A. 2019. Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus. Journal of clinical and translational endocrinology [online], 15, pages 35-36. Available from: https://doi.org/10.1016/j.jcte.2018.12.002

Insulin glargine is recombinant human insulin analog that is commonly used in patients with type 2 diabetes as well as those with type 1 diabetes. Pharmacokinetic and pharmacodynamics studies of insulin glargine had shown that it has an onset of acti... Read More about Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus..

Efficacy and safety of once daily liraglutide versus twice daily exenatide in type 2 diabetic patients in Qatar: an observational study. (2018)
Journal Article
JASSIM, Z., ELAJEZ, R., KHUDAIR, I., AL ANANY, R., AL-ADAWI, R.M. 2019. Efficacy and safety of once daily liraglutide versus twice daily exenatide in type 2 diabetic patients in Qatar: an observational study. Journal of pharmaceutical health services research [online], 10(1), pages 73-80. Available from: https://doi.org/10.1111/jphs.12240

Objective: Compare efficacy and safety of liraglutide (1.8 mg subcutaneous once daily) and exenatide (10 mcg subcutaneous twice daily) in uncontrolled type 2 diabetes at 26 and 52 weeks. Method: A retrospective observation study of uncontrolled type... Read More about Efficacy and safety of once daily liraglutide versus twice daily exenatide in type 2 diabetic patients in Qatar: an observational study..

The impact of pharmacists’ input on the screening, management and prevention of metabolic syndrome. [Protocol] (2018)
Other
AL ADAWI, R., TONNA, A., STEWERT, D., RAYAN, C., ELEDRISI, M., and ABDELAZIZ, H. [2018]. The impact of pharmacists’ input on the screening, management and prevention of metabolic syndrome. [Protocol]. PROSPERO [online], item number CRD42018089862. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018089862

The aim of this research was to critically appraise, synthesise, and present the available evidence on the impact of pharmacists' input on the screening, prevention and management of metabolic syndrome (MetS). The specific aims were: 1) To determine... Read More about The impact of pharmacists’ input on the screening, management and prevention of metabolic syndrome. [Protocol].

Prevalence of co-trimoxazole induced hyperkalemia in chronic and acute users in a tertiary teaching hospital. (2016)
Presentation / Conference
JASSIM, Z., MOUSTAFA, R. and AZIZ, H.A. 2016. Prevalence of co-trimoxazole induced hyperkalemia in chronic and acute users in a tertiary teaching hospital. Presented at 2016 Qatar Foundation annual research conference (ARC 16), 22-23 March 2016, Doha, Qatar.

Objective: The primary purpose of this research is to evaluate the risk of hyperkalemia in patients receiving co-trimoxazole. The secondary purpose is to detect the changes of potassium levels from baseline to 7, 14, 21, and 30 days, determine the as... Read More about Prevalence of co-trimoxazole induced hyperkalemia in chronic and acute users in a tertiary teaching hospital..

Assessment of medication adherence and factors contributing to non-adherence to calcium and vitamin D as mainstay in treatment and prophylaxis of osteoporosis. (2016)
Presentation / Conference
MOUSTAFA, R., JASSIM, Z., AZIZ, H.A., KHUDAIR, I. and SALEM, M. 2016. Assessment of medication adherence and factors contributing to non-adherence to calcium and vitamin D as mainstay in treatment and prophylaxis of osteoporosis. Presented at 2016 Qatar Foundation annual research conference (ARC 16), 22-23 March 2016, Doha, Qatar.

Objective: This study aimed to assess the adherence and persistence to Calcium and vitamin D, and address the reasons of non-adherence. Methods: All patients attending a secondary care rheumatology clinic in a teaching hospital serving a multiethnic... Read More about Assessment of medication adherence and factors contributing to non-adherence to calcium and vitamin D as mainstay in treatment and prophylaxis of osteoporosis..